CREB1 and non-small cell lung carcinoma: Further, treatment of NSCLC cells with the NMDA receptor antagonist MK-801 was shown to decrease phosphorylation of CREB, which is involved in regulating transcription of various cell cycle genes including p21 (Stepulak et al., 2005).